Abstract:OBJECTIVE:To investigate the mechanisms of the drug resistance of gemcitabine resistance variant of the human lung adenocarcinoma cell line A549-Gem.METHOD:Immunohistochemistry and RT-PCR were used to tested the expression of P-glycoprotein and transcription of mRNA of multidrug resistance gene and deoxycytidine kinase. Using a cDNA microarray compared the expression profiles between the resistant A549-Gem and the parent cell line A549.RESULTS:The A549-Gem shown slight positive expression of P-glycoprotein compared with positive control by immunohistochemistry, but A549 was negative for P-gp. RT-PCR amplified mRNA, using specific dCK and multidrug resistant gene 1 (mdr1) primers, demonstrated that A549-Gem express amplicon of mdr1 but no products of mdr1 was detected in A549. In the parent cell line, dCK mRNA amplication product could be detected, but did not found in resistant cells. About 18.8% of the total DNA elements had substantially altered level of expression in resistant A549-Gem compared with A549 by cDNA microarray. The biochemical functions of the different expressed genes are diverse and include oncogene and tumor suppressor gene, cell cycle regulator, heat shock protein, apoptotic and antiapoptotic factors, DNA transcription factors, DNA repair and recombination factors, signal transduction genes, protein translation genes, as well as a large number of metabolic genes. Several cluster genes overexpressed in resistant cell line, including ubiquitin-proteasome system, zinc finger protein, glutaredoxin and heat shock protein, may be related to the mechanisms of gemcitabine resistance.CONCLUSION:The mechanisms of resistance to gemcitabine are multifactorial, may include multidrug resistance and dCK deficiency. Differential expression genes monitored by cDNA microarray between A549-Gem and A549 may be related to the mechanisms of gemcitabine resistance in human lung cancer and potentially suggest the prevalence of expression of these genes in drug resistance. The use of cDNA microarray has provided a global view of the response of lung cancer cells to gemcitabine at the genomic level, it should be suitable for examining the development of drug resistance in cancer.

Identification of Drug Resistant Related Cdna in Lung Adenocarcinoma Cell Lines

[Cloning of Drug Resistance-Related Gene Fragments Differentially Expressed on Lung Adenocarcinoma Cell Line A549 and Its DDP-resistant Counterpart A549DDP].

Ddifferent expression of multidrug-resistance and apoptosis related genes in human lung adenocarcinoma parental cell line A549 and cisplatin-resistant cell line A549DDP

Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma

Difference of Drug-Resistance Between Single-Factor Resistance Cell Line K562/MDR1 Transfected with Mdr1 Gene and Multi-Factor Resistance Cell Line K562/A02 Induced by Doxorubicin.

[Identification of Multidrug Resistance Related Genes in Leukemia by Suppression Subtractive Hybridization].

[Mechanisms of the Drug Resistance of a 2', 2-Difluorodeoxycytide (Gemcitabine)-Resistant Variant of the Human Lung Adenocarcinoma Cell Line].

DEVELOPMENT OF A K562 MULTIDRUG-RESISTANT CELL LINE AND STUDY ON PROTEINS WITH ALTERED EXPRESSION

Screening differential expression of docetaxel-resistance related genes of human lung adenocarcinoma cell line SPC-A1 by cDNA microarray

Analysis of Micrornas in Drug-Resistant NSCLC Cell Line A549/DDP

Establishment of a Multidrug-resistance Cell Lines A549/CDDP from Human Lung Adenocarecinoma Cells

MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β-catenin signaling pathway

Genomic Analysis of Drug Resistant Small Cell Lung Cancer Cell Lines by Combining Mrna and Mirna Expression Profiling.

Integrated Analysis of DNA Methylation and Mrna Expression Profiling Reveals Candidate Genes Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer.

Screening and Cloning Multi-Drug Resistance Related Gene of Acute Myeloid Leukemia Cells

Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis

Mechanism of Drug Resistance Identified in Human Lung Adenocarcinoma Cell Line SPC-A1 Selected for Resistance to Docetaxel

Screening and Cloning of Multi-Drug Resistant Genes in HL-60/MDR Cells.

Identification of microRNAs and mRNAs associated with multidrug resistance of human laryngeal cancer Hep-2 cells.

Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line

[Expression of Drug Resistance and Metastasis Related Gene in Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma].